For years, conversations around trial diversity were framed as ethical or reputational concerns. That framing no longer reflects regulatory reality.
PhD, Co-Founder and CEO, Acclinate Stay up to date
Get news directly in your inbox
Boost inclusivity in your research with Acclinate.